Diabetes Clinical Trials in Denver

Showing 21-40 of 632 trials

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

NCT05018416

The purpose of this study is to assess the safety, efficacy, and durability of up to two Renal Autologous Cell Therapy (REACT) / rilparencel injections delivered percutaneously into biopsied and non-biopsied contralateral kidneys on renal function progression in two different cohorts of subjects with Type1 Diabetes Mellitus (T1DM) or Type2 Diabetes Mellitus(T2DM) and Chronic Kidney Disease (CKD).

Chronic Kidney DiseasesType 1 Diabetes MellitusType 2 Diabetes Mellitus

Prokidney53 participantsStarted Jul 2021

Denver, Colorado, United States • Newark, Delaware, United States • Nampa, Idaho, United States +2 more locations

COMPLETEDPhase 3< 1 mile

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

NCT01794143

The GRADE Study is a pragmatic, unmasked clinical trial that will compare commonly used diabetes medications, when combined with metformin, on glycemia-lowering effectiveness and patient-centered outcomes.

Type 2 DiabetesComparative Effectiveness of Glycemia-lowering Medications

GRADE Study Group7,850 participantsStarted May 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • San Diego, California, United States +33 more locations

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Diabetes Trials in Other Cities

Type 1 Diabetes Extension Study

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Colorado Community Engagement Alliance

T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Siplizumab in T1DM

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

Closed Loop and Education for Hypoglycemia Awareness Restoration

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

Other Conditions in Denver